06:31 AM EST, 11/06/2025 (MT Newswires) -- BeOne Medicines ( ONC ) reported Q3 adjusted earnings Thursday of $2.65 per diluted American depositary share, up from $0.48 a year earlier.

Analyst estimates were not readily available for comparison.

Total revenue for the quarter ended Sept. 30 was $1.41 billion, up from $1 billion a year earlier.

Analysts surveyed by FactSet expected $1.37 billion.

The company said it now expects 2025 total revenue in the range of $5.1 billion to $5.3 billion, compared with its prior range of $5 billion to $5.3 billion. Analysts polled by FactSet expect $5.22 billion.

Shares of the company were up more than 1% in recent premarket activity on Thursday.